Medicare proposes to expand payments to encourage trials of effectivenessBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39202.413912.DB (Published 03 May 2007) Cite this as: BMJ 2007;334:925
- Janice Hopkins Tanne
- New York
The US Centers for Medicare and Medicaid Services, which runs the federal Medicare health insurance plan for elderly people, last month proposed changes to how it pays for clinical trials.
If accepted, the changes would help Medicare compare existing treatments and make scientific and payment decisions that could save money while still providing effective treatment.
Under the current policy, developed in 2000, Medicare pays for certain items and services and for healthcare costs of Medicare beneficiaries who are taking part in clinical trials, but it does not pay for the “investigational” drugs, tests, and devices used in trials even when these drugs, tests, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial